Celldex Therapeutics, Inc.
CLDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000744218
No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.16B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Celldex Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +17 vs. Q1 2021
- Shares held
- 35.3M
- +769.6K (+2.2%) vs. Q1 2021
- Total value
- $1.19B
- +$484.4M (+68.3%) vs. Q1 2021
- New holders
- 40
- 33 more added
- Sold out
- 23
- 36 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 253 | $3.16B |
| Q1 2026 | 229 | $2.31B |
| Q4 2025 | 187 | $1.99B |
| Q3 2025 | 184 | $1.83B |
| Q2 2025 | 182 | $1.48B |
| Q1 2025 | 171 | $1.34B |
| Q4 2024 | 174 | $1.86B |
| Q3 2024 | 176 | $2.44B |
| Q2 2024 | 183 | $2.58B |
| Q1 2024 | 197 | $2.91B |
| Q4 2023 | 164 | $2.42B |
| Q3 2023 | 144 | $1.39B |
| Q2 2023 | 150 | $1.70B |
| Q1 2023 | 161 | $1.78B |
| Q4 2022 | 168 | $2.17B |
| Q3 2022 | 160 | $1.39B |
| Q2 2022 | 158 | $1.30B |
| Q1 2022 | 169 | $1.69B |
| Q4 2021 | 181 | $1.79B |
| Q3 2021 | 161 | $2.33B |
| Q2 2021 | 132 | $1.19B |
| Q1 2021 | 115 | $709.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Celldex Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HC Advisors, LLC | 6,416 | $215.0K | 0.13% | +6,416 | New |
| Cutler Group LP | 6,300 | $210.0K | 0.02% | +6,300 | New |
| Legal & General Group Plc | 6,103 | $204.0K | 0.00% | +4,402+258.8% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,151 | $139.0K | 0.00% | +1,673+67.5% | Added |
| Ameritas Investment Partners, Inc. | 3,074 | $103.0K | 0.00% | +3,074 | New |
| First Mercantile Trust Co | 2,920 | $98.0K | 0.01% | −594−16.9% | Reduced |
| Atlas Capital Advisors LLC | 2,700 | $90.3K | 0.02% | −300−10.0% | Reduced |
| Royal Bank of Canada | 2,684 | $90.0K | 0.00% | +2,684 | New |
| Great West Life Assurance Co | 2,550 | $85.0K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 1,534 | $51.3K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,510 | $50.5K | 0.00% | +1,189+370.4% | Added |
| Geneos Wealth Management Inc. | 1,333 | $45.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,347 | $45.0K | 0.00% | +1,347 | New |
| Panagora Asset Management Inc | 1,150 | $38.0K | 0.00% | −343−23.0% | Reduced |
| State of Wyoming | 1,037 | $36.0K | 0.02% | +709+216.2% | Added |
| Advisor Group Holdings, Inc. | 922 | $31.0K | 0.00% | 00.0% | Unchanged |
| Quantbot Technologies LP | 800 | $26.0K | 0.00% | +800 | New |
| US Bancorp | 406 | $14.0K | 0.00% | 00.0% | Unchanged |
| First Horizon Corp | 333 | $11.0K | 0.00% | 00.0% | Unchanged |
| Optimum Investment Advisors | 250 | $8.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 149 | $5.00K | 0.00% | −20−11.8% | Reduced |
| Northwestern Mutual Wealth Management Co | 113 | $4.00K | 0.00% | +13+13.0% | Added |
| Enterprise Financial Services Corp | 90 | $3.00K | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $3.00K | 0.00% | +100 | New |
| O'Shaughnessy Asset Management, LLC | 65 | $2.00K | 0.00% | 00.0% | Unchanged |
| Eaton Vance Management | 66 | $2.00K | 0.00% | +66 | New |
| NEXT Financial Group, Inc | 40 | $1.00K | 0.00% | 00.0% | Unchanged |
| Hartford Financial Management Inc. | 18 | $1.00K | 0.00% | +18 | New |
| Advisory Services Network, LLC | 17 | $1.00K | 0.00% | +17 | New |
| Evoke Wealth, LLC | 8 | $268 | 0.00% | 00.0% | Unchanged |
| Kelly Financial Services LLC | 1,538 | $46 | 0.00% | +1,492+3,243.5% | Added |
| Bourgeon Capital Management LLC | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −505,163−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −220,320−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −135,552−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −133,064−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −110,306−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −78,426−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −71,581−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −64,913−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −46,100−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −44,995−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −28,492−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −25,637−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −25,352−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −24,261−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −20,580−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −2,828−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| MPS Loria Financial Planners, LLC | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |